Boston Scientific Total Assets 2006-2019 | BSX

Boston Scientific total assets from 2006 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Boston Scientific total assets for the quarter ending March 31, 2019 were $23.802B, a 23.96% increase year-over-year.
  • Boston Scientific total assets for 2018 were $20.999B, a 10.28% increase from 2017.
  • Boston Scientific total assets for 2017 were $19.042B, a 5.23% increase from 2016.
  • Boston Scientific total assets for 2016 were $18.096B, a 0.2% decline from 2015.
Boston Scientific Annual Total Assets
(Millions of US $)
2018 $20,999
2017 $19,042
2016 $18,096
2015 $18,133
2014 $17,024
2013 $16,571
2012 $17,154
2011 $21,290
2010 $22,128
2009 $25,177
2008 $27,139
2007 $31,197
2006 $30,882
2005 $8,196
Boston Scientific Quarterly Total Assets
(Millions of US $)
Q1 2019 $23,802
Q4 2018 $20,999
Q3 2018 $20,379
Q2 2018 $19,615
Q1 2018 $19,202
Q4 2017 $19,042
Q3 2017 $18,636
Q2 2017 $18,382
Q1 2017 $17,943
Q4 2016 $18,096
Q3 2016 $17,697
Q2 2016 $17,838
Q1 2016 $17,718
Q4 2015 $18,133
Q3 2015 $18,215
Q2 2015 $17,123
Q1 2015 $16,472
Q4 2014 $17,024
Q3 2014 $16,718
Q2 2014 $16,477
Q1 2014 $16,335
Q4 2013 $16,571
Q3 2013 $16,917
Q2 2013 $16,996
Q1 2013 $16,763
Q4 2012 $17,154
Q3 2012 $16,898
Q2 2012 $17,818
Q1 2012 $21,185
Q4 2011 $21,290
Q3 2011 $21,502
Q2 2011 $21,559
Q1 2011 $22,070
Q4 2010 $22,128
Q3 2010 $22,486
Q2 2010 $23,019
Q1 2010 $22,853
Q4 2009 $25,177
Q3 2009 $26,229
Q2 2009 $26,193
Q1 2009 $26,105
Q4 2008 $27,139
Q3 2008 $29,826
Q2 2008 $29,901
Q1 2008 $30,346
Q4 2007 $31,197
Q3 2007 $31,334
Q2 2007 $31,265
Q1 2007 $31,069
Q4 2006 $30,882
Q3 2006 $30,752
Q2 2006 $30,611
Q1 2006 $9,109
Q4 2005 $8,196
Q3 2005 $8,076
Q2 2005 $8,083
Q1 2005 $7,819
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $56.933B $9.823B
Boston Scientific Corporation transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader they advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $147.168B 28.57
Medtronic (MDT) Ireland $131.379B 18.77
Stryker (SYK) United States $73.942B 26.39
Baxter (BAX) United States $41.099B 25.90
Zimmer Biomet Holdings (ZBH) United States $24.191B 15.54
Smith & Nephew SNATS (SNN) United Kingdom $18.938B 0.00
ResMed (RMD) United States $17.154B 32.78
Canopy Growth (CGC) Canada $14.483B 0.00
Bio-Rad Laboratories (BIO) United States $9.155B 48.53
Aurora Cannabis (ACB) Canada $7.667B 75.60
Insulet (PODD) United States $7.077B 515.65
Hill-Rom Holdings (HRC) United States $7.035B 21.33
Perrigo (PRGO) Ireland $5.966B 10.09
Haemonetics (HAE) United States $5.845B 47.71
GW Pharmaceuticals (GWPH) United Kingdom $5.309B 0.00
ICU Medical (ICUI) United States $4.968B 29.64
Hutchison China MediTech (HCM) China $3.770B 0.00
Neogen (NEOG) United States $3.289B 53.47
Agios Pharmaceuticals (AGIO) United States $3.048B 0.00
NuVasive (NUVA) United States $2.994B 24.45
National Vision Holdings (EYE) United States $2.410B 51.35
Quidel (QDEL) United States $2.275B 23.61
Aphria (APHA) $1.707B 0.00
Cardiovascular Systems (CSII) United States $1.521B 873.20
HEXO (HEXO) $1.425B 0.00
Phibro Animal Health (PAHC) United States $1.196B 17.92
AtriCure (ATRC) United States $1.169B 0.00
VAREX IMAGING (VREX) United States $1.109B 23.54
Lantheus Holdings (LNTH) United States $1.058B 28.10
OrganiGram Holdings (OGI) Canada $0.997B 0.00
NanoString Technologies (NSTG) United States $0.927B 0.00
PetIQ (PETQ) United States $0.900B 21.86
Quanterix (QTRX) United States $0.859B 0.00
Omeros (OMER) United States $0.823B 0.00
MacroGenics (MGNX) United States $0.817B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.748B 20.99
TG Therapeutics (TGTX) United States $0.684B 0.00
Cerus (CERS) United States $0.664B 0.00
Surmodics (SRDX) United States $0.569B 82.69
OraSure Technologies (OSUR) United States $0.540B 24.89
LeMaitre Vascular (LMAT) United States $0.526B 25.46
Meridian Bioscience (VIVO) United States $0.501B 15.31
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.368B 0.00
Evolus (EOLS) United States $0.362B 0.00
Vapotherm (VAPO) United States $0.357B 0.00
BioLife Solutions (BLFS) United States $0.335B 104.71
Utah Medical Products (UTMD) United States $0.318B 21.99
Zynex (ZYXI) United States $0.317B 32.73
Bovie Medical (APYX) United States $0.231B 0.00
Cytosorbents (CTSO) United States $0.203B 0.00
Owens & Minor (OMI) United States $0.182B 3.85
Chimerix (CMRX) United States $0.181B 0.00
Rockwell Medical (RMTI) United States $0.174B 0.00
Fonar (FONR) United States $0.136B 7.16
Female Health (VERU) United States $0.127B 0.00
BRAINSWAY LTD (BWAY) Israel $0.101B 0.00
Chembio Diagnostics (CEMI) United States $0.100B 0.00
InfuSystems Holdings (INFU) United States $0.092B 0.00
Surface Oncology (SURF) United States $0.092B 0.00
United-Guardian (UG) United States $0.088B 19.28
Neurotrope (NTRP) United States $0.087B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.061B 0.00
ImmuCell (ICCC) United States $0.048B 0.00
Trinity Biotech (TRIB) Ireland $0.038B 13.08
Senestech (SNES) United States $0.035B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.031B 0.00
GUARDION HEALTH (GHSI) United States $0.030B 0.00
Insys Therapeutics (INSY) United States $0.022B 0.00
Cellectar Biosciences (CLRB) United States $0.021B 0.00
Valeritas Holdings (VLRX) United States $0.017B 0.00
Myomo (MYO) United States $0.015B 0.00
Capricor Therapeutics (CAPR) United States $0.012B 0.00
Akers Biosciences Inc (AKER) United States $0.007B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.007B 0.00
NeuroMetrix (NURO) United States $0.005B 3.64